Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00004551 · ClinicalTrials.gov registry record · Phase 4
Behavioral Counseling for Alcohol Dependent Smokers (Nicotine Patch)
A Phase 4 study, sponsored by Mayo Clinic.
- Completed
- Registry status
- Phase 4
- Development phase
- 144
- Enrollment target
NCT00004551: Completed Phase 4 study, sponsored by Mayo Clinic.
NCT00004551 is a Phase 4 study that has completed, run by Mayo Clinic. The registered enrollment target is 144 participants, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (72% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00004551, a Phase 4 study, has completed, sponsored by Mayo Clinic.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 144 participants
- Enrollment target
Study Summary
This study is to evaluate the effectiveness of a mood management intervention on abstinent alcoholic smokers with a history of major depression. The second aim is to determine the effect of smoking treatments on alcohol abstinence and to identify factors associated with smoking and alcohol outcomes (e.g., more days of abstinence). A randomized, two-group design will be used to evaluate the added benefit of mood management compared to a state-of-the-art smoking cessation treatment. Treatment will consist of 8 weekly group sessions and 1, 3, 6, and 12-month follow-up.
Interventions
- DRUG nicotine replacement patch
- BEHAVIORAL mood management
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 144 participants |
| Start Date | 1999-02 |
| Est. Completion | 2003-01 |
| Phase | Phase 4 |
What the finished NCT00004551 record still lists
NCT00004551 is an interventional study that assigns participants to a tested intervention. The registered 144 participants enrollment target is mid-sized for trials with a published cap, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (72% lower).
The record links to 0 conditions, and to 2 interventions - of which nicotine replacement patch is the first listed.
NCT00004551 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00004551 about?
NCT00004551 is a clinical study titled "Behavioral Counseling for Alcohol Dependent Smokers (Nicotine Patch)". This study is to evaluate the effectiveness of a mood management intervention on abstinent alcoholic smokers with a history of major depression. The second aim is to determine the effect of smoking treatments on alcohol abstinence and to identify factors associated with smoking and alcohol outcomes ...
What is the current status of trial NCT00004551?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 144 participants. The study started on 1999-02. Estimated completion is 2003-01.
What interventions are being tested in trial NCT00004551?
The interventions under investigation include: nicotine replacement patch (DRUG), mood management (BEHAVIORAL).
Who is sponsoring clinical trial NCT00004551?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00004551's enrollment target sits among peer trials
144 577th of 2000 higher than 1,421 of 2,000 other Phase 4 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 4 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01861106 · 144 participants · Phase 2
Allogeneic Hematopoietic Stem Cell Transplant for GATA2 Mutations
- NCT03482245 · 144 participants · NA
The Role of Circadian Clock Proteins in Innate and Adaptive Immunity
- NCT03504683 · 144 participants · NA
MEAL TIMING Study: Effect of Time-Restricted Feeding on 24-hour Glycemic Control, Blood Pressure, and Cardiovascular Disease Risk Factors in Adults With Prediabetes
- NCT03905603 · 144 participants · Early Phase 1
Relative Contributions of Predictors of Hyperandrogenism in Older vs. Young Women With PCOS
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia